Urinary levels of podocyte-derived microparticles are associated with the progression of chronic kidney disease
Authors:
- 1 September 2019
- journal article
- research article
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 7 (18) , 445
Abstract
Background: Podocyte-derived microparticles (MPs) could be secreted from activated or apoptotic podocytes. An increased number of podocyte-derived MPs in the urine might reflect podocyte injury in renal diseases. This study aimed to observe the change of urinary podocyte-derived MP levels in patients with chronic kidney disease (CKD) and to further explore its correlation with the progression of CKD. Methods: A prospective, longitudinal study was conducted in eighty patients with biopsy-proven CKD. Podocyte-derived MPs (annexin V and podocalyxin positive) were detected by flow cytometry. The number of urinary podocyte-derived MPs was analyzed to evaluate the association with biochemical measurements and pathological glomerulosclerosis assessment. Patients with idiopathic membranous nephropathy (IMN) were followed up after the six-month treatment of prednisone combined with tacrolimus to evaluate the association of urinary podocyte-derived MP levels and the remission of IMN. Results: The CKD patients had higher urinary podocyte-derived MP levels compared with healthy controls (HCs). Baseline urinary levels of podocyte-derived MPs were positively correlated with 24-hour proteinuria, while were inversely correlated with the percentage of global glomerulosclerosis. The urinary podocyte-derived MPs levels had good discrimination for glomerulosclerosis [area under curve (AUC), 0.66]. The urinary podocyte-derived MPs levels in IMN patients were significantly decreased accompanied with the recovery of abnormal clinical parameters after six-month treatment. Conclusions: The urinary levels of podocyte-derived MPs were closely associated with podocyte injury and glomerulosclerosis, which could be useful for monitoring disease activity in CKD patients. Urinary podocyte-derived MPs might be a non-invasive biomarker for the evaluation of early CKD progression.Keywords
This publication has 26 references indexed in Scilit:
- Urinary Podocyte Microparticles Identify Prealbuminuric Diabetic Glomerular InjuryJournal of the American Society of Nephrology, 2014
- A Compendium of Urinary Biomarkers Indicative of Glomerular PodocytopathyPathology Research International, 2013
- Microparticles: biomarkers and beyondClinical Science, 2012
- Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxinDiabetologia, 2012
- TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-αLaboratory Investigation, 2011
- Glomerular filtration into the subpodocyte space is highly restricted under physiological perfusion conditionsAmerican Journal of Physiology-Renal Physiology, 2007
- Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discoveryKidney International, 2006
- Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cellsBlood, 2005
- Pattern of expression of the podocalyxin gene in the mouse brain during developmentGene Expression Patterns, 2005
- Effects of pentoxifylline administration on urinary N-acetyl-β-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized studyAmerican Journal of Kidney Diseases, 2003